Context Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is a common condition
that causes severe symptoms, bother, and quality-of-life impact in the 8.2% of men who are …

Background Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is a common
disorder in which the two main clinical features are pelvic pain and lower urinary tract …

Background: Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), also known as
NIH Category III Prostatitis is a highly prevalent syndrome with significant impact on quality …

Objectives To improve awareness and recognition of chronic bacterial prostatitis (CBP) and
chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) among non‐specialists and …

Context Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is common, but trial
evidence is conflicting and therapeutic options are controversial. Objective To conduct a …

BACKGROUND: The assessment of patients with chronic prostatitis/chronic pelvic pain
syndrome (CP/CPPS) in everyday practice and clinical studies relies on National Institutes of …

OBJECTIVES: To perform a Canadian multicenter randomized placebo-controlled trial to
evaluate the safety and efficacy of 6 weeks of levofloxacin therapy compared with placebo in …

Urologists and physicians who treat male patients spend a significant percentage of their
clinical practice time diagnosing and managing prostate disease. Prostate cancer is the …

BACKGROUND: National Institutes of Health (NIH) category III prostatitis/chronic pelvic pain
syndrome (CP/CPPS) is a prevalent condition for which no standardised treatment exists …

Background In men with chronic prostatitis–chronic pelvic pain syndrome, treatment with
alpha-adrenergic receptor blockers early in the course of the disorder has been reported to …